Antineutrophil Cytoplasmic Antibody–Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap With Significant Implications for Treatment and Outcomes
Arthritis & Rheumatology · 2026
DOI: 10.1002/art.70032 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Deborah Eshagh und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cochin Hospital, AP-HP, Paris, France. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Scleroderma, Systemic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Objective
Systemic sclerosis (SSc) is an autoimmune disease characterized by autoantibody production, fibrosis, and vasculopathy. The coexistence of antineutrophil cytoplasmic autoantibody (ANCA)–associated vasculitides (AAV) in SSc is rare and poorly characterized, with limited data on the impact of treatments, particularly high‐dose glucocorticoids (GCs), on both conditions. This study aimed to describe the clinical phenotype, management, and outcomes of patients with overlapping SSc and AAV.
Methods
We conducted a multicenter retrospective study in 18 French centers, including patients who met the 2013 American College of Rheumatology (ACR)/EULAR criteria for SSc and the 2022 ACR/EULAR criteria for AAV. Clinical, biologic, and radiologic data were collected.
Results
We included 30 patients (median age 51.5 years, 83% female). SSc preceded AAV in all cases; 27% had diffuse cutaneous SSc, whereas 73% had limited cutaneous SSc. Anti‐Scl70 antibodies were detected in 50%, and interstitial lung disease (ILD) was present in 80%, predominantly with a fibrosing nonspecific interstitial pneumonia pattern (54%). AAV was microscopic polyangiitis in 90%, with myeloperoxidase (MPO)–ANCA positivity in 93%. Renal involvement was common (76%), with a median serum creatinine level of 170 μmol/L (interquartile range [IQR] 120–361 μmol/L) and proteinuria (urine protein to creatinine ratio of 2 g/g creatinine [IQR 0.9–2.3 g/g creatinine]). All patients received GCs in combination with cyclophosphamide (50%) or rituximab (47%). No cases of scleroderma renal crisis were observed. SSc manifestations, including ILD and skin involvement, remained stable during follow‐up.
Conclusion
AAV, predominantly microscopic polyangiitis with MPO‐ANCA, can occur in SSc, particularly in patients with fibrosing ILD and anti‐Scl70. Standard vasculitis treatments appear to be effective and do not worsen outcomes in SSc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Cochin Hospital, AP-HP, Paris, France.
- Department of Internal Medicine, Centre Hospitalier, Valenciennes, France.
- Department of Nephrology, Georges Pompidou Hospital, AP-HP, Paris, France.
- Department of Internal Medicine, Centre Hospitalier Universitaire, Nice, France.
- Department of Nephrology, Centre Hospitalier Universitaire, Angers, France.
- Nantes Université, Centre Hospitalier Universitaire Nantes, Service de médecine interne, Nantes, France.
ORCID-Profile: Deborah Eshagh, Jean-Francois Augusto, Stanislas Faguer, Noémie Jourde-Chiche, Benjamin Chaigne, Alexis Régent, Xavier Puéchal, Benjamin Terrier
Zitieren
APA
Eshagh, D., Quéméneur, T., Karras, A., Queyrel, V., Augusto, J. F., Agard, C., Audard, V., Cez, A., Couderc, M., Duffau, P., Durel, C. A., Faguer, S., Jourde-Chiche, N., Lavergne, A., Lavigne, C., Limal, N., Mesbah, R., Servettaz, A., Philipponnet, C., …, & French Vasculitis Study Group (2026). Antineutrophil Cytoplasmic Antibody–Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap With Significant Implications for Treatment and Outcomes. Arthritis & Rheumatology. https://doi.org/10.1002/art.70032
Vancouver
Eshagh D, Quéméneur T, Karras A, Queyrel V, Augusto JF, Agard C, et al. Antineutrophil Cytoplasmic Antibody–Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap With Significant Implications for Treatment and Outcomes. Arthritis & Rheumatology. 2026. doi:10.1002/art.70032
BibTeX
@article{Eshagh2026,
author = {Eshagh, Deborah and Quéméneur, Thomas and Karras, Alexandre and Queyrel, Viviane and Augusto, Jean-Francois and Agard, Christian and Audard, Vincent and Cez, Alexandre and Couderc, Marion and Duffau, Pierre and Durel, Cécile Audrey and Faguer, Stanislas and Jourde-Chiche, Noémie and Lavergne, Aurélie and Lavigne, Christian and Limal, Nicolas and Mesbah, Rafik and Servettaz, Amélie and Philipponnet, Carole and Smets, Perrine and Hubsch, Theophile and Chaigne, Benjamin and Régent, Alexis and Puéchal, Xavier and Mouthon, Luc and Terrier, Benjamin and French Vasculitis Study Group, French Vasculitis Study Group},
title = {Antineutrophil Cytoplasmic Antibody–Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap With Significant Implications for Treatment and Outcomes},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.70032}
}
EUVIMED